Silverarc Capital Management, LLC Verastem, Inc. Transaction History

Silverarc Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.54 - $4.07 $2.67 Million - $4.27 Million	-1,049,357 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.57 - $4.85 $380,699 - $718,440	-148,132 Reduced 12.37%	1,049,357 $4.27 Million
Q1 2021 May 18, 2021	BUY	$1.9 - $2.82 $117,298 - $174,095	61,736 Added 5.44%	1,197,489 $2.96 Million
Q4 2020 Feb 16, 2021	BUY	$1.15 - $2.4 $1.31 Million - $2.73 Million	1,135,753 New	1,135,753 $2.42 Million

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $796M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.